RUSSIAVILLE, Ind. — Earlier this month, the Federal Trade Commission sent three companies letters regarding the claims they were making about their cannabis-derived products. They told them they need to review the claims, as well as consumer testimonials, about their products and provide reliable scientific research to back it up.
The FTC said one company claims CBD works like “magic” to relieve severe pain. The agency said the specific company claims CBD has been clinically proven to treat diseases like cancer, Alzheimer’s disease and multiple sclerosis.
The FTC said another company receiving a letter claimed CBD products can treat autism, anorexia, cancer and AIDs. Then, the third company, according to the FTC, promotes their CBD edible gummies as having the ability to treat most major degenerative diseases, and their CBD oil may effectively treat PTSD, depression, epilepsy and other diseases.
“Making these wild claims on these products, on the CBD products they’re selling such as, ‘It cures cancer,’ that’s kind of the number one way to get the attention of both of those federal agencies,” Justin Swanson, Midwest Hemp Council President, said of the FTC and the Food and Drug Administration.
Greg Kruger works 12 hours or more a day to keep his “Dreem” alive. He is the chief operating officer with DREEM Nutrition in Russiaville.